Evolving Therapeutic Options for Polycythemia Vera: Perspectives of the Canadian Myeloproliferative Neoplasms (MPN) Group
In this report, we assess the potential impact of the changing landscape of PV management on daily practice.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer & Oncology | Leukemia | Lymphoma | Myeloma | Myeloproliferative Disorders | Phlebotomy | Stem Cell Therapy | Stem Cells | Study | Thrombosis